Featured Jobs
|
DWC - The 401(k) Experts
|
|
Relationship Manager - Defined Contributions Daybright Financial
|
|
PPS Pension Services
|
|
Compass
|
|
Frank Pension Consultants, Ltd.
|
|
DWC - The 401(k) Experts
|
|
Compass
|
|
Defined Contribution Account Manager Nova 401(k) Associates
|
Free Newsletters
“BenefitsLink continues to be the most valuable resource we have at the firm.”
-- An attorney subscriber
|
|
|
|
International Prescription Drug Price Comparisons: Current Empirical Estimates and Comparisons with Previous Studies
Assistant Secretary for Planning and Evaluation [ASPE], U.S. Department of Health and Human Services [HHS]
July 1, 2022 "U.S. prices were 256 percent of those in the 32 comparison countries combined. In comparisons with individual countries, U.S. prices ranged from 170 percent of prices in Mexico to 779 percent of prices in Turkey. The gap between U.S. prices and prices in other countries was larger for brand-name originator drugs. U.S. prices were 84 percent of prices in all non-U.S. countries for unbranded generics. U.S. prices were 190 percent of prices in other countries after adjusting U.S. prices downward to account for rebates and other discounts." |
| Please click here to report this link if it is broken (for example, if you see a "404 File Not Found" error message after you click on the linked news item's title). |
| An important word about authorship: BenefitsLink® created this link to the news item, but we are not the news item's author (unless expressly shown above). |